INCY vs VTRS — Key Metrics
| Metric | INCY (INCYTE CORP) | VTRS (VIATRIS INC) |
|---|---|---|
| Price | 117.8 | 20.28 |
| Market Cap | 24.01 Billion | 23.25 Billion |
| P/E (TTM) | 56.36 | -38.26 |
| P/B (Quarterly) | 4.219 | 1.589 |
| P/S (TTM) | 3.99 | 1.58 |
| Net Profit Margin (TTM) | 6.7 | -4.1 |
| Gross Margin (TTM) | 92.7 | 35.3 |
| ROE (TTM) | 7.1 | -4.2 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Outperform
Greatly Outperform
Recommendation Summary
Both stocks are projected to significantly outperform the market over the next year. If you have to make a choice, Upfront Recommendation: INCY.
Financial Metrics
| INCY | Metrics | VTRS |
|---|---|---|
| $117.80 | Price | $20.28 |
| — | Market Capitalization | — |
| 3.99 | Price to Sales | 1.58 |
| 35.06 | Price to FCF Ratio | 10.85 |
| 4.31 | Price to Gross Profit | 4.47 |
| 6.99 | Price to R&D | 23.17 |
| 4.35 | Price to Current Assets | 2.26 |
INCY vs VTRS at a glance
Incyte Corp (INCY) and Viatris INC (VTRS) are both in the Healthcare sector. They are similar in size: $24.0 billion and $23.3 billion in market value.
On trailing-twelve-month figures, INCY trades at 4.0 times trailing sales and VTRS at 1.6; net profit margins are 6.7% and -4.1%.
The Upfront Investment model currently rates both Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.